Bausch Health Com…
USUSDBausch Health Companies Inc (TO:BHC) — Biotechnology: Pharmaceutical Preparations. Antal børser, hvor selskabets aktier handles: 2. På denne side — kurs og diagram, udbytte, største aktionærer og historik over antal aktier.
Om Virksomheden
- Websted
- bauschhealth.com
- Investorrelationer
- ir.bauschhealth.com/
- Sektor
- Health Care · Biotechnology: Pharmaceutical Preparations
- Hovedkontor
- Laval, Canada
- Administrerende Direktør
- Joseph C. Papa
- Ansatte
- 20 300
- Grundlagt
- 1960
- Børsnoteret Siden
- 03.04.1996 (TO:BHC)
- Udestående Aktier
- Free Float
- 260.57 mio.
- Markedsværdi
- 2.17 mia. USD
- Insidere
- 11.12%
- Institutionelle Investorer
- 65.02%
- Branche (SIC)
- Pharmaceutical Preparations
- ISIN
- CA91911K1021
- LEI
- KOO0397YRO83WY5MGD97
- P/E
- underskud
- Udbetalingsgrad
- underskud
- FCF
- 1.43 mia. USD
- Udbetaling / FCF
- 25%
- Gæld
- 20.7 mia. USD13 år FCF
- Udbyttestreak
- —
- Indtjening, FCF og udbetalt udbytte — for de 12 måneder frem til 30.06.2026 (selskabets seneste rapport).
- NAV
Beskrivelse
Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company. It operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The company develops, manufactures, and markets products primarily in the therapeutic areas of gastroenterology, hepatology, neurology and dermatology, generic and branded generic pharmaceuticals, dentistry products, over-the-counter products, aesthetic medical devices, and eye health. The company sells its products in the United States, China, Canada, Poland, Mexico, France, South Korea, Russia, Japan, Germany, the United Kingdom, Spain, Italy, and internationally. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.
Udbytte
Ingen udbyttebetalinger fundet (tjekket 15.10.2026). Virksomheden udbetaler sandsynligvis ikke udbytte.
Største Ejere
| Ejer | Andel | Aktier | Rapportdato |
|---|---|---|---|
| PAULSON JOHN A. (Directo… | ≈19.7% | 73.69 mio. | 2026-06-30 |
| PAULSON & CO., INC. (Ben… | 19.58% | 73.26 mio. | 2026-06-30 |
| Goldentree Asset Managem… | 9.27% | 34.67 mio. | 2026-06-30 |
| Royal Bank of Canada | 2.9% | 10.83 mio. | 2026-06-30 |
| Healthcare of Ontario Pe… | 2.14% | 8 mio. | 2026-06-30 |
| Vanguard Capital Managem… | 2% | 7.47 mio. | 2026-06-30 |
| Goldman Sachs Group Inc | 1.66% | 6.23 mio. | 2026-06-30 |
| MFN Partners Management,… | 1.6% | 6 mio. | 2026-06-30 |
| SG Americas Securities,… | 1.48% | 5.54 mio. | 2026-06-30 |
| Acadian Asset Management… | 1.47% | 5.48 mio. | 2026-06-30 |
| Kohlberg Kravis Roberts… | 1.4% | 5.24 mio. | 2026-06-30 |
| VANGUARD STAR FUNDS-Vang… | 1.01% | 3.76 mio. | 2026-04-30 |
| APPIO THOMAS J (Chief Ex… | ≈0.97% | 3.62 mio. | 2026-02-25 |
| VANGUARD TAX-MANAGED FUN… | 0.66% | 2.48 mio. | 2026-06-30 |
| SCHWAB STRATEGIC TRUST-S… | 0.38% | 1.41 mio. | 2026-05-31 |
| VANGUARD Intl Eqy. INDEX… | 0.26% | 957 190 | 2026-04-30 |
| DFA INVESTMENT TRUST CO-… | 0.22% | 815 010 | 2026-07-31 |
| CHARHON JEAN-JACQUES (Ch… | ≈0.2% | 755 538 | 2026-02-25 |
| CARSON SEANA LYNNE (Gene… | ≈0.16% | 616 761 | 2026-03-03 |
| SCHWAB STRATEGIC TRUST-S… | 0.15% | 542 712 | 2026-05-31 |
| DFA INVESTMENT DIMENSION… | 0.12% | 431 311 | 2026-04-30 |
| SPDR INDEX SHARES Fd.S-S… | 0.11% | 405 303 | 2026-08-31 |
| iShares Trust-iShares Co… | 0.1% | 377 486 | 2026-07-31 |
| iShares Trust-iShares Co… | 0.1% | 358 322 | 2026-07-31 |
| LENAR AIMEE J (Officer) | ≈0.09% | 334 853 | 2026-08-19 |
| WECHSLER AMY B (Director… | ≈0.08% | 313 585 | 2026-05-22 |
| POWER ROBERT N (Director… | ≈0.08% | 300 594 | 2026-05-22 |
| KAVANAGH SARAH BALDWIN (… | ≈0.08% | 282 230 | 2026-05-22 |
| MILLER STEVEN D (Directo… | ≈0.06% | 239 224 | 2025-05-16 |
